Green Cross Health (GXH) AGM Presentation summary

Financial performance highlights

• Operating revenue rose 4% to $523.8m, driven by acquisitions and strong pharmacy dispensary performance, partially offset by retail decline.

• Operating profit increased to $38.7m, reflecting top line growth and operational improvements.

• Net profit after tax attributable to shareholders grew to $16.0m, with EPS at 11.1 cps.

• Final FY25 dividend of 2.75 cps declared, with total dividends paid during the year at 7.0 cps.

• Gearing ratio at 11.9% and net cash position of $1.8m as of 31 March 2025; $52.6m operating cash flow enabled investments and debt repayment.

Pharmacy division performance and strategy

• Pharmacy revenue up 2% to $370.4m, with operating profit rising to $21.5m due to growth and store optimisation.

• 38 million script items dispensed, with a 4% same-store growth in script items.

• Care & Advice Health Hubs expanded, with 77,000 online bookings and 326,000 vaccinations administered.

• Beauty by Life concept launched, enhancing in-store experience and product range.

• Living Rewards membership exceeded 2.09 million, with members spending 50% more than non-members.

Medical division performance and strategy

• Medical revenue up 9% to $153.4m, driven by acquisitions and operational improvements.

• Operating profit increased to $19.5m; 416,500 enrolled patients and ownership in 65 medical centres.

• Employee costs reduced to 72% of revenue through operational efficiency and technology.

• Major refurbishments and rebranding continued, with over 120,000 app users and 16,000 telehealth consults.

• Focus on innovative care models, direct funding advocacy, and continuous operational improvement.